Publications

A next generation BCG vaccine moves forward.

DOCKRELL, HM;

2022

The Lancet. Infectious diseases, (2022).22 10 10.1016/s1473-3099(22)00287-0.

Optimising Xpert-Ultra and culture testing to reliably measure tuberculosis prevalence in the community: findings from surveys in Zambia and South Africa.

FLOYD, S; Klinkenberg, E; De Haas, P; Kosloff, B; GACHIE, T; Dodd, PJ; RUPEREZ, M; Wapamesa, C; Burnett, MJ; Kalisvaart, N; Vermaak, R; Mainga, T; SCHAAP, A; Fidler, S; Mureithi, L; Shanaube, K; HAYES, R; AYLES, H; TREATS study team,;

2022

BMJ Open, (2022).12 6 10.1136/bmjopen-2021-058195.

Population benefits of addressing programmatic and social determinants of gender disparities in tuberculosis in Viet Nam: A modelling study.

HORTON, KC; WHITE, RG; Hoa, NB; Nguyen, HV; Bakker, R; SUMNER, T; CORBETT, EL; HOUBEN, RM G J;

2022

PLOS Global Public Health, (2022).2 7 10.1371/journal.pgph.0000784.

Editorial: Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans.

Seshadri, C; SUTHERLAND, JS; Lindestam Arlehamn, CS; Burel, JG;

2022

Frontiers in immunology, (2022).12, 10.3389/fimmu.2021.830920.

Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 49 high burden countries.

MCQUAID, CF; BURKE, RM; Henrion, M; Law, I; MacPherson, P; Soko, R; HORTON, K;

2022

(2022).

Drug-Resistant Tuberculosis Treatment Outcomes among Children and Adolescents in Karachi, Pakistan.

Malik, AA; Khan, U; KHAN, P; Anwar, A; Salahuddin, N; Khowaja, S; Khan, AJ; Khan, S; Hussain, H; Amanullah, F;

2022

Tropical medicine and infectious disease, (2022).7 12 10.3390/tropicalmed7120418.

Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.

Khundi, M; CARPENTER, JR; CORBETT, EL; FEASEY, HR A; Soko, RN; Nliwasa, M; Twabi, H; Chiume, L; BURKE, RM; HORTON, KC; Dodd, PJ; Cohen, T; MacPherson, P;

2022

PloS one, (2022).17 5 10.1371/journal.pone.0268749.

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Antimycobacterial Susceptibility Testing Group,;

2022

European Respiratory Journal, (2022).59 4 10.1183/13993003.00166-2022.

Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.

EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; Shaikh, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; HOUBEN, RM G J;

2022

medRxiv (2022). 10.1101/2022.06.09.22276188.

Design and protocol for a cluster randomised trial of enhanced diagnostics for tuberculosis screening among people living with HIV in hospital in Malawi (CASTLE study).

BURKE, RM; Nyirenda, S; Twabi, HH; Nliwasa, M; Joekes, E; Walker, N; Nyirenda, R; Gupta-Wright, A; FIELDING, K; MacPherson, P; CORBETT, EL;

2022

PloS one, (2022).17 1 10.1371/journal.pone.0261877.